26 February 2016
2016 marks a decade since the National Institute for Health and Care Research (NIHR) was established. Throughout the last ten years it has contributed significantly to the health and wealth of the nation and is now the most comprehensive research system in the world. NIHR CLAHRC West is proud to be a part of this world-leading research institute.
The NIHR supports research from bench to bedside for the benefit of patients and the economy. It works with patients and the public to shape the research agenda, finding new ways of preventing, identifying and treating ill health, evaluating the effectiveness and impact of new healthcare treatments, and ensures that the best possible evidence is available to inform decisions about health and social care.
The NIHR attracts investment into the UK by supporting partnerships with life science companies, including small and medium enterprises, and charities, and builds capacity and leadership in the research workforce.
The work of the NIHR has had a significant impact on the research landscape and has been growing year on year. In 2014/15:
The latest annual report highlights more activity undertaken by the NIHR.
Read how the NIHR was created and has developed throughout the decade
The NIHR has developed a series of information sheets about its work and activities in key areas:
The Research Excellence Framework (REF), a system for assessing the quality of research, has recognised the major role played by the NIHR in underpinning the outstanding quality and impact of research in the health and life sciences produced by universities working in collaboration with the NHS.
A report from its ‘Main Panel A’ and its sub-panels said:
“We consider that the overall increased NIHR funding seen since 2006 and decisions to maintain government science funding in times of economic hardship have had a positive influence in the increased quality of the outputs…and has put the UK in a very strong position worldwide in research.
“The increasing investment made by the NIHR since 2006 has had an enormous beneficial effect on the ability of universities to translate their research into patient benefit.”
In 2015, RAND Europe conducted an economic analysis of the impact of research funded under the NIHR’s Health Technology Assessment (HTA) programme to understand its potential economic benefits.
Rand reported that the 10 projects that were examined could bring benefits worth approximately £3 billion if the new treatments were used in the NHS for one year. This figure includes both cost savings for the NHS and the health benefit to patients converted into financial terms.